Ubs Global Asset Management Americas »

Krystal Biotech shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 20k 124.06
2023-09-30 $2.4M 20k 116.00
2023-06-30 $1.3M 17k 80.06
2023-03-31 $1.3M 17k 80.06
2022-12-31 $1.2M 16k 79.22
2022-09-30 $1.1M 16k 69.70
2022-06-30 $999k 15k 65.66
2022-03-31 $1.0M 15k 66.54
2021-12-31 $713k 10k 69.95
2021-09-30 $455k 8.7k 52.21
2021-06-30 $592k 8.7k 68.00
2021-03-31 $722k 9.4k 77.04
2020-12-31 $459k 11k 43.05
2020-09-30 $459k 11k 43.05
2020-06-30 $224k 5.4k 41.42
2020-03-31 $254k 5.9k 43.24
2019-12-31 $227k 4.1k 55.38